Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2017 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017

LEXINGTON, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today...
November 02, 2017 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update

Submitted 510(k) Application to the FDA Requesting Market Clearance for T2Bacteria PanelYear over Year Quarterly Product Revenue Growth of 27.4% LEXINGTON, Mass., Nov. 02, 2017 (GLOBE NEWSWIRE) --...
November 01, 2017 08:01 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Attend the Canaccord Medical Technologies and Diagnostics Forum

LEXINGTON, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development of innovative diagnostic products to improve patient health, today...
October 16, 2017 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces 2017 Third Quarter Financial and Operational Results Release and Conference Call Date

LEXINGTON, MA, Oct. 16, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development of innovative diagnostic products to improve patient health, today announced...
October 12, 2017 10:44 ET | Source: T2 Biosystems, Inc.

Clinicians Discuss Positive Impact of T2MR Platform on Sepsis Care at IDWeek 2017

LEXINGTON, Mass., Oct. 12, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today...
October 03, 2017 07:00 ET | Source: T2 Biosystems, Inc.

Study Published in Journal of Antimicrobial Stewardship Shows Patients Diagnosed with T2Candida Panel Treated More Than Eight Times Faster

LEXINGTON, Mass., Oct. 03, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today...
September 21, 2017 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Presentations at IDWeek 2017

LEXINGTON, Mass., Sept. 21, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today...
September 18, 2017 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Present at the Cantor Fitzgerald Global Healthcare Conference

LEXINGTON, Mass., Sept. 18, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today...
September 15, 2017 08:20 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Pricing of Public Offering of Common Stock

LEXINGTON, Mass., Sept. 15, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced the pricing of an underwritten registered public offering of 4,375,000 shares of common stock...
September 14, 2017 16:11 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Proposed Public Offering of Common Stock

LEXINGTON, Mass., Sept. 14, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that it is commencing an underwritten registered public offering of shares of its common stock....